Similar Articles
521 Shuyu pills inhibit immune escape and enhance chemosensitization in hepatocellular carcinoma
522 Anatomical vs nonanatomical liver resection for solitary hepatocellular carcinoma: A systematic review and meta-analysis
523 Hepatocellular carcinoma biomarkers, an imminent need
524 Gut microbiome composition can predict the response to nivolumab in advanced hepatocellular carcinoma patients
525 Hepatocellular carcinoma risk after viral response in hepatitis C virus-advanced fibrosis: Who to screen and for how long?
526 Artificial neural network for prediction of acute kidney injury after liver transplantation for cirrhosis and hepatocellular carcinoma
527 Long-term survival outcome of laparoscopic liver resection for hepatocellular carcinoma
528 Research progress regarding programmed cell death 1/programmed cell death ligand 1 inhibitors combined with targeted therapy for treating hepatocellular carcinoma
529 Outcomes of reduction hepatectomy combined with postoperative multidisciplinary therapy for advanced hepatocellular carcinoma
530 Single dose dexamethasone prophylaxis of postembolisation syndrome after chemoembolisation in hepatocellular carcinoma patient: A randomised, double-blind, placebo-controlled study
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA